Abstract
Objective: This article describes a clinical case and demonstrates the implications of the late diagnosis of Neurogenic Bladder (NB), a consequence of Myelomeningocele (MMC), showing the importance of early diagnosis to prevent complications and improve the quality and life expectancy of patients with this dysfunction. Case details: Female patient, 42-year-old, diagnosed at birth with MMC. At the age of four, after urinary tract infections, she was diagnosed with NB and left renal agenesis, and underwent cystostomy. Asymptomatic for upto 15 years, she manifested severe anemia, hypoxia and oliguria, serum creatinine 13.6 mg/dL and serum urea 177 mg/dL, diagnosed with chronic kidney disease (CKD) and initiated renal replacement therapy. She developed systemic arterial hypertension, erythropoietin deficiency anemia, secondary hyperparathyroidism with visible growth deficit and significant left ventricular hypertrophy. Final considerations: Despite the increase in life expectancy of patients with MMC, there are few studies on their conduct and long-term follow-up. The development of CKD and complications related to this pathology in these patients can be avoided. More research is needed on this topic, aiming to improve the quality of life of these individuals and reduce expenses and comorbidities.